GlassScriptPhysician profile
Warren David Johnston
NPI 1427052802
$4,395.37
in general payments reported to CMS, 2019-2025
20 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,319 · 2020: $117 · 2021: $576 · 2022: $1,361 · 2023: $368 · 2024: $542 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,022.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,022.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,219.15 | 2019-2024 | Mitraclip, 2nd Gen Centrimag Primary Console |
| Medtronic, INC. | $507.41 | 2021-2022 | |
| Amgen INC. | $421.90 | 2019-2025 | Repatha, Repatha |
| Medtronic Vascular, INC. | $395.11 | 2019 | |
| Sanofi-Aventis U.S. LLC | $354.77 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $346.25 | 2022-2024 | |
| Actelion Pharmaceuticals US, INC. | $229.27 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $221.81 | 2019-2025 | Camzyos, Eliquis |
| Edwards Lifesciences Corporation | $173.72 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Janssen Pharmaceuticals, INC | $168.52 | 2019-2023 | Xarelto |
| Pfizer INC. | $131.21 | 2019-2023 | |
| Biotronik INC. | $40.00 | 2019 | |
| Heartflow, INC. | $39.52 | 2019-2020 | |
| Cvrx, INC. | $32.52 | 2022 | |
| Kestra Medical Technology Services, INC. | $24.93 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $23.85 | 2023 | Amvuttra |
| Gilead Sciences, INC. | $23.22 | 2019 | |
| Astellas Pharma US INC | $16.94 | 2021 | |
| Cardiva Medical, INC. | $14.34 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Atricure, INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.